This indicated that PLCG2 might be an essential factor in predicting and remodeling the CRC immune microenvironment, especially in close relation to CD8+ T cells, and might be an important molecular target for modulating CD8+ T cells as well as for reversing CRC immune escape. The gene discussed is PLCG2; the disease is colorectal carcinoma.